Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1949 1
1951 1
1954 2
1955 1
1957 2
1958 2
1960 1
1961 3
1962 8
1963 5
1964 4
1965 14
1966 4
1967 2
1968 1
1969 2
1970 5
1971 4
1972 8
1973 1
1974 4
1975 1
1976 3
1977 5
1978 7
1979 10
1980 12
1981 10
1982 9
1983 9
1984 4
1985 6
1986 7
1987 10
1988 6
1989 4
1990 9
1991 8
1992 6
1993 4
1994 4
1995 2
1996 2
1997 5
1998 1
1999 5
2000 5
2001 2
2002 4
2003 7
2004 5
2005 15
2006 16
2007 5
2008 9
2009 9
2010 11
2011 16
2012 30
2013 17
2014 21
2015 15
2016 17
2017 16
2018 18
2019 17
2020 43
2021 51
2022 56
2023 44
2024 49
2025 40
2026 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

717 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean xsaxena k[au] (2,164 results)?
Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.
Li BT, Smit EF, Goto Y, Nakagawa K, Udagawa H, Mazières J, Nagasaka M, Bazhenova L, Saltos AN, Felip E, Pacheco JM, Pérol M, Paz-Ares L, Saxena K, Shiga R, Cheng Y, Acharyya S, Vitazka P, Shahidi J, Planchard D, Jänne PA; DESTINY-Lung01 Trial Investigators. Li BT, et al. Among authors: saxena k. N Engl J Med. 2022 Jan 20;386(3):241-251. doi: 10.1056/NEJMoa2112431. Epub 2021 Sep 18. N Engl J Med. 2022. PMID: 34534430 Free PMC article. Clinical Trial.
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer.
Yoshino T, Di Bartolomeo M, Raghav K, Masuishi T, Loupakis F, Kawakami H, Yamaguchi K, Nishina T, Wainberg Z, Elez E, Rodriguez J, Fakih M, Ciardiello F, Saxena K, Kobayashi K, Bako E, Okuda Y, Meinhardt G, Grothey A, Siena S; DESTINY-CRC01 investigators. Yoshino T, et al. Among authors: saxena k. Nat Commun. 2023 Jun 7;14(1):3332. doi: 10.1038/s41467-023-38032-4. Nat Commun. 2023. PMID: 37286557 Free PMC article.
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial.
Siena S, Di Bartolomeo M, Raghav K, Masuishi T, Loupakis F, Kawakami H, Yamaguchi K, Nishina T, Fakih M, Elez E, Rodriguez J, Ciardiello F, Komatsu Y, Esaki T, Chung K, Wainberg Z, Sartore-Bianchi A, Saxena K, Yamamoto E, Bako E, Okuda Y, Shahidi J, Grothey A, Yoshino T; DESTINY-CRC01 investigators. Siena S, et al. Among authors: saxena k. Lancet Oncol. 2021 Jun;22(6):779-789. doi: 10.1016/S1470-2045(21)00086-3. Epub 2021 May 4. Lancet Oncol. 2021. PMID: 33961795 Clinical Trial.
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets.
Schwalm MP, Dopfer J, Kumar A, Greco FA, Bauer N, Löhr F, Heering J, Cano-Franco S, Lechner S, Hanke T, Jaser I, Morasch V, Lenz C, Fearon D, Marples PG, Tomlinson CWE, Brunello L, Saxena K, Adams NBP, von Delft F, Müller S, Stolz A, Proschak E, Kuster B, Knapp S, Rogov VV. Schwalm MP, et al. Among authors: saxena k. Nat Commun. 2024 Nov 25;15(1):10204. doi: 10.1038/s41467-024-54409-5. Nat Commun. 2024. PMID: 39587067 Free PMC article.
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses.
DiNardo CD, Verma D, Baran N, Bhagat TD, Skwarska A, Lodi A, Saxena K, Cai T, Su X, Guerra VA, Poigaialwar G, Kuruvilla VM, Konoplev S, Gordon-Mitchell S, Pradhan K, Aluri S, Hackman GL, Chaudhry S, Collins M, Sweeney SR, Busquets J, Rathore AS, Deng Q, Green MR, Grant S, Demo S, Choudhary GS, Sahu S, Agarwal B, Spodek M, Thiruthuvanathan V, Will B, Steidl U, Tippett GD, Burger J, Borthakur G, Jabbour E, Pemmaraju N, Kadia T, Kornblau S, Daver NG, Naqvi K, Short NJ, Garcia-Manero G, Tiziani S, Verma A, Konopleva M. DiNardo CD, et al. Among authors: saxena k. Nat Cancer. 2024 Oct;5(10):1515-1533. doi: 10.1038/s43018-024-00811-3. Epub 2024 Sep 19. Nat Cancer. 2024. PMID: 39300320 Clinical Trial.
A Short-Lived Crisis.
Saxena K, Dhaliwal G, Rao MN, Babik JM. Saxena K, et al. J Hosp Med. 2021 Oct;16(10):623-627. doi: 10.12788/jhm.3568. J Hosp Med. 2021. PMID: 34328846 No abstract available.
Opioid-free anaesthesia: The conundrum and the solutions.
Gupta L, Agarwal J, Saxena KN. Gupta L, et al. Among authors: saxena kn. Indian J Anaesth. 2022 Mar;66(Suppl 2):S91-S94. doi: 10.4103/ija.ija_256_22. Epub 2022 Mar 25. Indian J Anaesth. 2022. PMID: 35601042 Free PMC article. No abstract available.
Pallister-Killian syndrome: Review of fetal phenotype.
Thakur S, Gupta R, Tiwari B, Singh N, Saxena KK. Thakur S, et al. Among authors: saxena kk. Clin Genet. 2019 Jan;95(1):79-84. doi: 10.1111/cge.13381. Epub 2018 Jun 29. Clin Genet. 2019. PMID: 29790157 Review.
717 results